A Study of the Efficacy and Safety of Relacorilant in Patients With Endogenous Cushing Syndrome

NCT03697109 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

152

Enrollment

INDUSTRY

Sponsor class

Conditions

Cushing Syndrome

Interventions

DRUG: Relacorilant
OTHER: Placebo

Sponsor

Corcept Therapeutics